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Summary
Background.  —  Fontan  circulation  is  fragile  and  unfavourable  evolution  is  frequent.  Fontan
physiology  largely  depends  on  respiration  and  gravity.  The  hypothesis  for  valvulation  is  that
valvulation  of  the  circuit  reduces  the  effects  of  respiration  and  the  proclive  position,  and
increases anterograde  ﬂow  towards  the  systemic  circulation,  with  increasing  exercise  capacity
and beneﬁts  for  enteropathy.  Because  it  originates  from  the  bovine  jugular  vein,  the  Melody®
valve  (Medtronic,  Minneapolis,  MN,  USA)  is  naturally  designed  to  work  in  a  low-pressure  envi-
ronment.
Aims. —  To  report  our  experience  of  percutaneous  valvulation  of  refractory  failing  Fontan  cir-
culation.
Methods.  —  We  reviewed  all  patients  who  received  a  Melody  valve  in  Fontan  circulation  in  our
unit.
Results.  —  Four  patients  were  included:  two  had  severe  and  refractory  protein-losing  enteropa-
thy; one  had  severe  oedema  and  ascites;  and  one  had  very  severe  lower  limb  venous
Abbreviations: IVC, Inferior vena cava; NYHA, New York Heart Association; PLE, Protein-losing enteropathy; TCPC, Total cavopulmonary
connection; TTE, Transthoracic echocardiography.
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insufﬁciency.  The  Melody  valve  was  successfully  implanted  in  all  patients.  Central  venous  pres-
sure and  inferior  vena  cava  pressure  did  not  change  after  valvulation.  There  were  no  early
complications.  At  follow-up,  no  acute  or  mid-term  thrombosis  was  noted.  Two  patients  had
intracardiac  echocardiography  6  and  24  months  after  valvulation:  the  Melody  valve  was  found
not to  be  functioning  in  both  cases.  One  patient  died  3  months  after  valvulation;  the  cause  was
unrelated to  the  procedure.
Conclusion.  —  Percutaneous  valvulation  of  Fontan  circulation  is  technically  feasible.  More  clin-
ical studies  are  needed  before  considering  this  treatment  as  an  option.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  — La  circulation  de  Fontan  est  fragile  avec  une  évolution  emaillée  de  nombreuses
complications.  Sa  physiologie  est  unique  et  dépend  beaucoup  de  la  respiration  et  de  la  gravité.
L’hypothèse  de  l’effet  favorable  de  la  valvulation  est  que  la  mise  en  place  d’une  valve  dans  le
circuit réduit  les  effets  de  la  respiration  et  de  la  position  proclive.  Ce  faisant,  la  valvulation
augmente  le  débit  antérograde  de  la  circulation  systémique  améliorant  la  capacité  à  l’effort  et
peut également  diminuer  les  signes  d’entéropathie  exsudative.  La  valve  Mélody® (Medtronic,
Minneapolis,  MN,  États-Unis)  qui  est  issue  de  la  jugulaire  de  bœuf  est,  de  par  son  origine,
naturellement  faite  pour  fonctionner  dans  un  environnement  à  basse  pression.
Objectif.  —  Nous  rapportons  notre  expérience  de  la  valulation  percutanée  de  circuits  de  Fontan
défaillants  et  réfractaires  au  traitement  médical  conventionnel.
Méthodes.  —  Tous  les  patients  ayant  rec¸u  une  valve  Mélody  dans  une  circulation  de  Fontan  ont
été revus.
Résultats.  —  Quatre  patients  ont  été  inclus  :  deux  patients  avaient  une  entéropathie  exsuda-
tive sévère  et  réfractaire  aux  traitements  conventionnels  ;  un  patient  était  en  anasarque  avec
une ascite  importante  ;  et  le  dernier  présentait  de  très  larges  varices  invalidantes  des  mem-
bers inférieurs.  La  Mélody  a  été  implantée  chez  les  quatre  patients  avec  succès.  Les  pressions
veineuses centrales  et  caves  inférieures  n’ont  pas  été  modiﬁées  par  la  valvulation.  Il  n’y  a  pas
eu de  complications  précoces  ni  tardives.  Durant  le  suivi,  il  n’y  a  pas  eu  de  thrombose  aiguë  ou
chronique  démontrée.  Deux  patients  ont  eu  une  échographie  intracardiaque  respectivement  à
6 et  24  mois  après  valvulation  :  il  n’y  avait  pas  de  fonction  valvulaire  observée.  Un  patient  est
décédé 3  mois  après  la  procédure  sans  relation  avec  celle-ci.
Conclusions.  — La  valvulation  percutanée  est  aisément  réalisable.  D’autres  études  cliniques
sont nécéssaires  avant  de  considérer  ce  traitement  comme  option  thérapeutique  en  cas  de
défaillance de  circulation  de  Fontan.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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he  Fontan  procedure  provides  good  palliation  for  patients
ith  single  ventricular  physiology  [1].  However,  this  non-
hysiological  circulation  is  fragile,  and  many  patients  will
xperience  a  variety  of  end-organ  complications  and  unique
orbidities  [2,3].  Complications  are  varied  and  can  be
nspeciﬁc,  such  as  ventricular  dysfunction,  arrhythmias
nd  global  cardiac  failure,  or  more  speciﬁc  to  the  failing
ontan,  such  as  liver  ﬁbrosis,  protein-losing  enteropathy
PLE)  and  plastic  bronchitis.  These  complications  are  the
onsequences  of  a  complex  physiology  involving  circula-
ory  insufﬁciency,  inﬂammation  and  lymphatic  derangement
4,5].  Management  strategies  are  emerging,  but  current
reatments  are  usually  palliative,  with  modest  results,  and
nce  severe  complications  occur,  life  expectancy  is  short-
ned  [6].  Heart  transplantation  is  the  only  treatment,  but
s  technically  challenging  and  the  outcome  is  poorer  than  in
ther  diseases  requiring  heart  transplantation  [7].
c
p
c
hThe  use  of  stents  in  Fontan  circuits  has  been  reported  in
arious  situations,  with  good  results;  they  have  been  placed
n  pulmonary  arteries  to  relieve  stenosis  and  in  the  extrac-
rdiac  conduit  to  treat  acute  thrombosis  [8,9]. Recently,  we
eported  the  use  of  a covered  stent  to  close  fenestration,
ith  a  good  result  and  no  thromboembolic  complications
10].
Fontan  physiology  is  unique.  Cardiac  output  in  this  set-
ing  is  almost  exclusively  preload  dependent  and  varies
ith  gravity  and  respiration  [11].  Part  of  the  inferior  vena
ava  (IVC)  blood  ﬂows  back  into  the  abdominal  compart-
ent  during  expiration.  The  importance  of  respiration  in
he  Fontan  circulation  has  been  evaluated  in  in  vitro  exper-
mental  models,  but  also  by  computational  ﬂuid  dynamic
tudies  [12,13]. This  phenomenon  is  emphasized  in  the  pro-
live  position;  decrease  of  cardiac  output  is  noticed  in  this
osition  and  might  be  responsible  for  decreased  exercise
apacity,  liver  cirrhosis  and  PLE  [14,15].  We  and  others
ave  hypothesized  that  valvulation  of  the  Fontan  pathway
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reduces  respiratory  variations  and  decreases  the  effects
of  gravity  and  the  proclive  position.  As  a  result,  valvula-
tion  theoretically  increases  preload  and  cardiac  output,  and
might  improve  exercise  capacity  and  decrease  PLE.  This
hypothesis  is  also  supported  by  recent  mathematical  and
in  vitro  studies  [16,17].
There  is  long-term  experience  of  valved  Fontan  in  the  ini-
tial  period,  showing  poor  results,  related  to  early  stenotic
degeneration  of  the  surgically  implanted  valve.  Two  recent
changes  made  us  resuscitate  this  option:  availability  of
transcatheter  valved  stents;  and  a  potentially  good  substi-
tute  —  the  Melody® valve  (Medtronic,  Minneapolis,  MN,  USA).
In  the  early  days,  valvulation  was  done  using  an  aortic  valve
(mostly  human  or  porcine);  because  of  their  origins,  these
valves  are  thick  and  are  designed  to  work  at  high  pressures.
The  Melody  valve  is  a  bovine  jugular  vein  sutured  in  a  stent;
this  valve  is  thin  and  is  designed  to  work  in  a  low-pressure
environment.
Because  of  the  lack  of  therapeutic  options,  we  sought  to
offer  alternative  palliation  for  patients  with  failing  Fontan
despite  maximal  medical  treatment.  Percutaneous  valvula-
tion  of  the  Fontan  circuit  was  offered  to  these  patients,
using  a  Melody  valve.  To  date,  this  is  the  ﬁrst  report  on  per-
cutaneous  valve  implantation  in  a  Fontan  circulation.  We
review  the  results  of  percutaneous  valvulation  of  Fontan
circuit  and  report  on  the  acute  and  chronic  effects  of  this
procedure.
Methods
Patients  who  received  a  Melody  valve  in  a  failing  Fontan
circulation  were  reviewed  in  our  institution.  The  patients
had  various  complications  related  to  the  Fontan  circulation
despite  maximal  medical  treatment.  Exclusion  criteria  were
anatomical  abnormalities  responsible  for  Fontan  dysfunc-
tion  and  contraindication  to  anticoagulation  or  antiplatelet
therapy.
All  patients  presented  with  severe  symptoms  of  Fontan
failure;  they  were  all  on  maximal  medical  treatment  and
were  aware  of  the  lack  of  other  therapeutic  options.  The
cardiologist  in  charge  of  the  patient  explained  the  technical
details  of  the  valvulation  and  the  potential  beneﬁts  of  the
c
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Table  1  Demographic  characteristics.
Patient  1  Patient  2  
Age  (years)  29  14  
CHD  Tricuspid
atresia
Complex  D
Palliation Fenestrated
extracardiac
Fontan
Extracardi
Fontan
NYHA  III  II—III  
Complications  PLE,  liver
ﬁbrosis
PLE  
CHD: congenital heart disease; DORV: double outlet right ventricle; NYH
ventricular septum; PLE: protein-losing enteropathy.601
rocedure  to  the  patient  and  their  family.  The  absence  of
edical  data  regarding  percutaneous  valvulation  in  this  set-
ing  was  also  mentioned  to  the  patient.  Informed  consent
as  obtained  from  each  patient.
Because  of  their  heterogeneity  and  number,  patients  are
resented  as  individual  cases.  Data  on  patient  character-
stics,  surgical  history  and  clinical  status  before  and  after
mplantation  are  provided  for  each  patient.
esults
our  patients  had  a  Melody  valve  implanted  in  a  failing
ontan;  they  all  presented  with  a  severe  medical  condition
econdary  to  a  failing  Fontan  circulation  despite  maximal
edical  treatment.  All  valves  were  implanted  from  the
emoral  vein.  Results  are  summarized  in  Tables  1,  2  and  3.
ase 1
 29-year-old  woman  with  tricuspid  atresia  was  referred  for
LE  in  2011.  The  patient  had  a pulmonary  artery  band  in
nfancy  followed  by  a  Blalock  shunt  at  the  age  of  2  years.
t  the  age  of  5 years,  she  had  a  Fontan  operation  with  an
ortic  homograft  between  the  right  atrium  and  pulmonary
rtery.  In  2010,  she  presented  atrial  ﬁbrillation  and  cardiac
ailure,  pleural  effusion  and  ascites,  and  received  a  Fontan
onversion  with  a  20  mm  extracardiac  conduit.  The  patient
resented  with  hypoalbuminaemia,  major  ascites,  elevated
lpha-1  antitrypsin  clearance  and  polyclonal  increase  in
amma  globulins;  she  was  on  high  doses  of  diuretics,  vitamin
 antagonists,  beta-blockers  and  digoxin,  and  was  in  New
ork  Heart  Association  (NYHA)  functional  class  III.  Transtho-
acic  echocardiography  (TTE)  showed  good  systolic  function
f  the  systemic  ventricle,  dilated  IVC  with  contrast  and  no
eﬂux  in  the  IVC  or  portal  vein.
Cardiac  catheterization  was  performed  under  gen-
ral  anaesthesia.  The  right  femoral  vein  was  punctured.
ressures  were  low  (14  mmHg  in  the  total  cavopulmonary
onnection  [TCPC];  10  mmHg  in  the  capillaries).  No  anatomi-
al  abnormality  was  seen  on  angiography.  A  Melody  valve  was
laced  in  the  conduit  using  a  22  mm  Ensemble® (Medtronic,
inneapolis,  MN,  USA)  delivery  catheter.  No  prestenting  was
Patient  3  Patient  4
21  25
ORV  PA-IVS  PA-IVS
ac Fenestrated
extracardiac
Fontan
Classical
Fontan
III  II
Oedema,
ascites
Lower  limb
venous
insufﬁciency
A: New York Heart Association; PA-IVS: pulmonary atresia, intact
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Table  2  Haemodynamic  data.
Patient  1  Patient  2  Patient  3  Patient  4
Baseline  (mmHg)
CVP  14  17  14  15
Wedge  pressure  10  12  10  10
Post-valvulation  (mmHg)
CVP  14  17  19  15
CVP: central venous pressure.
Table  3  Follow-up  duration  and  status.
Patient  1  Patient  2  Patient  3 Patient  4
Follow-up  (months)  28  3a 28  24
Clinical  status  No  PLE  Transient  improvement  Stable  Stable
PLE: protein-losing enteropathy.
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was  stopped  abruptly,  making  acute  adrenocortical  insuf-
ﬁciency  a  possible  cause  of  death.Sudden death after 3 months.
one.  On  angiography,  the  Melody  valve  was  competent.
ressures  were  not  modiﬁed  after  valvulation.  Compres-
ion  was  done  manually.  No  procedural  complications  were
eported.
After  a  follow-up  of  28  months,  the  patient  is  stable  with-
ut  PLE.  Diuretics  have  been  decreased  and  NYHA  functional
lass  has  improved  slightly.  Normalization  of  albuminaemia
as  observed  after  26  months  of  follow-up.  On  TTE,  ventri-
ular  systolic  function  is  good  and  IVC  is  not  dilated.
ase 2
 14-year-old  boy  with  complex  double  outlet  right  ven-
ricle  treated  as  a  single  ventricle  presented  with  severe
LE  despite  maximal  treatment  (diuretics,  low-molecular-
eight  heparin,  steroids,  albumin  infusions).  The  patient
ad  an  extracardiac  cavopulmonary  connection  and  had
ndergone  several  surgical  valvuloplasties  of  the  two
trioventricular  valves.  The  patient  had  developed  many
omplications  secondary  to  steroid  treatment,  includ-
ng  avascular  necrosis  of  the  hip  and  peritonitis  treated
y  antibiotics  followed  by  surgical  appendicectomy.  The
atient  was  considered  for  transcatheter  valvulation  of  the
CPC;  at  this  time,  he  was  in  NYHA  functional  class  III.
n  TTE,  systolic  function  of  the  systemic  ventricle  was
ood,  with  moderate  tricuspid  valve  regurgitation.  IVC  was
ilated,  with  reﬂux  in  the  hepatic  veins  but  not  in  the  IVC.
ardiac  catheterization  was  done  under  general  anaesthe-
ia.  The  right  femoral  vein  was  punctured.  Pressures  were
ildly  elevated  (17  mmHg  in  the  pathway;  mean  wedge
ressure  12  mmHg).  A  Melody  valve  was  positioned  in  the
onduit  with  a  22  mm  Ensemble  delivery  catheter  (Fig.  1).
o  prestenting  was  needed.  Post-valvulation  pressures
ere  unchanged.  Compression  was  done  manually  without
ny  problems.  The  procedure  was  uncomplicated.  Post-
rocedure,  PLE  improved.  The  boy  was  weaned  off  albumin
F
2nfusion;  other  medications  (diuretics,  heparin  1  dose/day
nd  steroids)  were  progressively  reduced.
Three  months  after  valvulation,  the  patient  was  admit-
ed  with  status  epilepticus  and  multiple  ionic  abnormalities.
n  admission,  echocardiography  showed  normal  ﬂow  in
he  TCPC  and  normal  heart  function.  The  patient  died
f  ventricular  ﬁbrillation  secondary  to  uncorrected  ionic
bnormalities  while  waiting  for  a  cerebral  computed  tomo-
raphy  scan.  An  autopsy  was  refused  and  aetiology  of
eath  remains  unknown.  At  interrogation,  corticosteroidigure 1. Angiogram showing a competent Melody valve (patient
).
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Figure 2. Intracardiac echocardiography (patient 3). A. Inferior vena cava (IVC) Doppler, spontaneous breathing, before valvulation. B.
 valv
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anterograde ﬂow; no valvular function. D. IVC Doppler during breat
Case 3
A  21-year-old  woman  with  pulmonary  atresia  and  intact
ventricular  septum  came  to  our  attention  with  ascites  and
oedema  despite  high  doses  of  diuretics.
The  patient  had  received  a  neonatal  Blalock  shunt
followed  by  a  Glenn  procedure  and  an  intracardiac  cavopul-
monary  connection  at  the  age  of  4  years.  In  2006,  she  had
a  Fontan  conversion  with  a  20  mm  extracardiac  conduit.
Six  months  later,  because  of  anasarca,  cardiac  catheteriza-
tion  was  done  and  the  right  pulmonary  artery  was  stented.
Because  of  elevated  venous  pressure,  the  fenestration  was
reopened  using  a  bare-metal  stent,  with  good  initial  results.
Oxygen  saturation  was  85%  after  the  creation  of  the  fen-
estration.  In  2011,  TTE  showed  moderate  impairment  of
systolic  function  of  the  left  ventricle  (ejection  fraction  50%)
and  a  mildly  dilated  IVC  with  reﬂux  in  the  hepatic  veins.  The
patient  was  in  NYHA  functional  class  III.
Cardiac  catheterization  was  done  under  general  anaes-
thesia.  The  right  femoral  vein  was  punctured.  Mean
pressures  were  low  (14  mmHg  in  the  TCPC;  10  mmHg  in
the  capillaries).  Angiography  showed  reﬂux  in  the  IVC.  A
Melody  valve  was  placed  in  the  extracardiac  conduit  below
the  fenestration  without  previous  prestenting.  Moderate
elevation  of  central  pressure  to  19  mmHg  was  noted  after
valvulation,  but  the  patient  received  a  high  dose  of  con-
trast  dye.  Oxygen  saturation  increased  from  85%  to  90%  after
valvulation.  Valvular  function  was  observed  on  intracardiac
f
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Nular click. C. IVC Doppler in apnoea, post-valvulation: continuous
 valvular closure during expiration.
chocardiography  (Fig.  2);  indeed,  a  valvular  click  was
ecorded  on  Doppler  measurements.  The  opening  of  the
alve  correlated  with  respiration.  Compression  was  done
anually  without  any  difﬁculties.  The  procedure  was
ncomplicated.
No  clear  beneﬁt  of  valvulation  was  reported  (other  than
tabilization  of  clinical  status)  during  the  follow-up.  The
atient  had  a  second  haemodynamic  evaluation  6 months
fter  valvulation  (Fig.  3).  Pressures  were  unchanged.  Intrac-
rdiac  echography  showed  no  thrombus  in  the  Melody  valve
nd  no  gradient  across  the  valve.  On  two-dimensional
mages,  valvular  motion  of  the  leaﬂets  was  recorded  but  the
alve  was  signiﬁcantly  regurgitant  on  colour  ﬂow  Doppler.
fter  28  months  of  follow-up,  the  patient  is  stable  without
egradation  of  status.
ase 4
 25-year-old  woman  with  pulmonary  atresia  and  intact
entricular  septum  was  referred  because  of  very  severe
ower  limb  venous  insufﬁciency  with  large  vein  varicosis.
he  patient  had  neonatal  anastomosis  and  a right  ventricle-
o-pulmonary  artery  opening,  and  had  a  classical  Fontan
peration  at  the  age  of  2  years.  A  pacemaker  was  implanted
or  sinus  dysfunction  at  the  age  of  24  years.  TTE  showed
ood  systolic  function  of  the  left  ventricle,  competent  mitral
alve  and  dilated  IVC  without  reﬂux.  The  patient  was  in
YHA  functional  class  II.
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wigure 3. Intracardiac echocardiography (patient 3). Six months
fter valvulation: no valvular click; retrograde ﬂow during expira-
ion.
Cardiac  catheterization  was  done  under  general  anaes-
hesia  after  puncture  of  the  right  femoral  vein.  Pressures
ere  low  (15  mmHg  in  the  pathway;  10  mmHg  in  the  capillar-
es).  A  covered  Cheatham-platinum  stent  was  implanted  in
he  IVC  to  create  a  safe  landing  zone,  followed  by  implan-
ation  of  a  Melody  valve  mounted  in  the  22  mm  delivery
atheter.  Post-valvulation,  pressures  remained  unchanged.
alve  function  was  tested  with  variation  of  the  respiratory
ycle  in  the  declive  and  proclive  positions  using  intracar-
iac  echocardiography.  The  proclive  position  was  achieved
y  moving  the  table  until  the  patient  was  lying  at  an  angle
f  up  to  30◦.  The  patient  was  not  intubated  but  was  deeply
edated  and  ventilated  with  non-invasive  positive  pressure.
alve  function  was  highly  dependent  on  respiratory  cycle,
unctioning  at  high  frequency  (≥  30  cycles/min)  and  dys-
unctioning  below  this  level.  Gravity  alone  did  not  improve
alve  function  but  it  improved  valve  function  at  high  respi-
atory  frequency.  Venous  insufﬁciency  did  not  improve  after
alvulation.
Twenty-four  months  after  valvulation,  cardiac  catheter-
zation  was  done  for  haemodynamic  evaluation  and  valvular
ssessment  using  intracardiac  echocardiography.  Pressures
ere  low  (12  mmHg).  No  gradient  across  the  valve  was
ecorded.  Intravascular  echocardiography  showed  no  throm-
us  formation.  There  was  no  evidence  of  valvular  function,
ven  in  the  proclive  position  and  with  a  high  respiratory  rate.
eaﬂets  could  not  be  seen.  The  Melody  valve  appeared  like
 non-valved  conduit.  Retrograde  ﬂow  was  seen  in  the  IVC
nd  no  valvular  click  was  recorded.  No  calciﬁcation  of  the
onduit  was  seen  on  ﬂuoroscopy  and  cine  angiography.
iscussion
he  Fontan  operation  provides  good  palliation  for  patients
ith  univentricular  hearts  [1].  Surgical  techniques  have
volved  over  the  past  few  decades,  leading  to  better
esults  and  the  long-term  survival  of  these  patients.  Nev-
rtheless,  many  of  these  patients  will  develop  a  wide
ange  of  complications  [2—4],  most  of  which  are  the  result
f  complex  physiology  and  are  incompletely  understood
4,5].  Some  therapies  have  been  developed  to  treat  these
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atastrophic  complications,  but  efﬁcacy  is  low  and  life
xpectancy  is  reduced  [6].  Once  the  Fontan  has  failed,  the
nly  therapeutic  option  is  heart  transplantation,  but  with  a
igh  mortality  rate  [7].
The  physiology  of  the  Fontan  circulation  is  unique.  It  has
een  termed  paradoxical,  in  that  systemic  venous  hyperten-
ion  (mean  pressure  >  10  mmHg)  occurs  simultaneously  with
ulmonary  arterial  hypotension  (mean  pressure  <  15  mmHg)
18]. The  most  important  determinant  of  cardiac  output
s  preload  [11], which  is  determined  by  the  amount  of
lood  returning  in  the  heart;  it  is  affected  by  systemic
enous  return  and  pulmonary  vascular  resistance.  Focus-
ng  on  systemic  venous  return,  some  studies  have  reported
hat  infradiaphragmatic  venous  ﬂow  is  markedly  dependent
n  respiration  and  gravity  in  Fontan  patients,  with  gravity
aving  an  adverse  effect  on  portal  and  IVC  ﬂow  [12,13].
aemodynamic  studies  on  patients  with  failing  Fontan  have
emonstrated  that  one  of  the  main  components  of  the  symp-
oms  of  chronic  Fontan  failure  is  liver  ﬁbrosis  and  portal
ypertension  secondary  to  elevation  of  venous  pressure.
art  of  the  circulatory  dysfunction  in  failing  Fontan  mimics
irculatory  dysfunction  in  portal  hypertension,  with  splanch-
ic  arterial  vasodilatation  because  of  reduced  hepatic
erfusion,  followed  by  arterial  hypotension,  renal  hypoper-
usion  and  activation  of  the  renin-angiotensin-aldosterone
ystem,  resulting  in  ﬂuid  retention.  Preservation  of  the  liver
s  thus  a  key  issue  in  the  treatment  of  Fontan  [5].
Valved  conduits  have  been  used  in  Fontan  surgery  [19].
ndeed,  homografts  were  used  to  reduce  backward  ﬂow  in
he  true  Fontan  operation,  which  was  later  abandoned  by
ost  centres.  The  bovine  jugular  vein  is  used  surgically
Contegra®;  Medtronic,  Minneapolis,  MN,  USA)  and  percu-
aneously  (Melody)  for  the  treatment  of  right  ventricular
utﬂow  tract  reconstruction  and  in  the  tricuspid  position,
ith  good  results  [20—22]. The  valve  is  thin,  coming  from
he  venous  system,  and  is  designed  to  work  in  a low-pressure
nvironment,  making  it  a  good  candidate  for  valvulation  of
he  Fontan  circulation.  Experimental  studies  on  this  valve
ave  demonstrated  that  little  or  no  reﬂux  is  needed  to  close
he  valve  [23].
Our  hypothesis  was  that  valvulation  of  the  failing  Fontan
ircuit  with  the  Melody  valve  would  reduce  the  adverse
ffects  of  gravity  and  respiration  by  reducing  retrograde
ow  and  thus  increasing  anterograde  net  ﬂow  and  preload.
n  the  four  patients  studied,  valvulation  was  straightforward
ithout  complications.  Acutely,  no  pressure  changed  was
bserved.  Despite  valve  functioning,  no  clinical  improve-
ent  was  noticed  early  after  valvulation.  PLE  improved  or
tabilized  in  two  patients,  but  it  is  not  known  if  this  was
elated  to  the  procedure.  The  last  two  patients  had  cath-
terization  6  months  and  24  months  after  implantation  of
he  Melody  valve.  Deterioration  of  the  valve  was  observed
n  intracardiac  echocardiography:  at  6  months,  valvular
eaﬂets  were  observed,  but  with  regurgitation;  and  at
 years  from  implantation,  no  valvular  function  was  noticed
n  intracardiac  echocardiography.  The  reasons  for  valvu-
ar  disappearance  are  unknown.  We  found  similar  behaviour
hen  we  implanted  the  Melody  valve  in  the  IVC  in  a  chronic
xperimental  model  [24].
This  study  was  conducted  to  ﬁnd  an  alternative  treat-
ent  for  chronic  venous  insufﬁciency,  a  frequent  vascular
isease.  The  results  of  the  study  were  disappointing,  unlike
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other  acute  studies,  in  that  at  autopsy,  the  valve  leaﬂets
were  completely  embedded  in  the  vascular  wall,  leaving
an  opened  non-valved  conduit  [25].  We  hypothesized  that
a  valve  needs  to  be  constantly  functioning  to  keep  working.
Similar  results  have  been  reported  in  the  clinical  setting
when  the  Melody  valve  was  inserted  in  the  tricuspid  posi-
tion  in  patients  with  unfavourable  haemodynamic  conditions
[26].  Interestingly,  intracardiac  echocardiography  provided
us  with  very  interesting  information.  The  role  of  respira-
tion  should  be  noted.  We  showed  that  the  closure  of  the
valve  was  only  present  when  the  respiratory  rate  was  ≥  30
cycles/min,  which  is  higher  than  the  normal  respiratory  rate
at  rest  in  children  and  adults.  Gravity  alone  did  not  affect
valve  function.  This,  of  course,  was  tested  with  patients
deeply  sedated,  using  non-invasive  ventilation.  We  agree
that  this  is  not  a  physiological  situation,  but  we  do  think
that  it  mimics  closely  what  happens  in  the  normal  breathing
situation.  Moreover,  it  allowed  us  to  test  various  variables,
such  as  respiratory  rate,  inspiration/expiration  time  ratio
and  level  of  positive  expiratory  pressure.
Study limitations
This  series  is  very  limited.  Although  no  spectacular  clinical
improvement  was  demonstrated,  three  patients  were  sta-
ble,  stabilized  or  had  improvement  in  PLE  for  almost  2  years.
This  apparent  stability  could  be  considered  a  positive  end-
point  because  of  the  natural  evolution  of  failing  Fontan.  The
different  nature  of  the  complications  and  the  heterogene-
ity  of  the  patients  make  deﬁnitive  conclusions  very  difﬁcult
to  draw.  The  exact  effect  of  the  valve  remains  unknown.
Additional  evaluation  (i.e.  magnetic  resonance  imaging  and
exercise  testing)  would  have  been  interesting,  to  evaluate
more  accurately  the  effect  of  valvulation.  Patients  refused
to  have  additional  testing.  The  risk  of  the  procedure  is  very
low  in  patients  with  an  extracardiac  TCPC  made  of  a  Goretex
conduit.  Besides  questioning  the  effectiveness  of  the  proce-
dure,  long-term  complications  may  occur,  making  cautious
follow-up  of  value.  In  particular,  endocarditis  and  thrombo-
sis  are  of  concern,  as  with  all  cardiac  valves.
Conclusions
Once  Fontan  fails,  few  treatments  are  useful,  apart  from
heart  transplantation,  with  its  own  long-term  problem.  In
light  of  this,  we  offered  percutaneous  valvulation  to  patients
with  failing  Fontan.  Despite  modiﬁcations  of  the  echocar-
diography  —  particularly  modulation  of  hepatic  ﬂow  —  no
spectacular  clinical  beneﬁt  was  observed.  Valve  function
was  not  obvious  in  implanted  patients  in  the  long  term,
but  assessment  remains  difﬁcult,  requiring  invasive  assess-
ment  by  intracardiac  echocardiography  in  our  cases.  Patient
selection  remains  very  important.  At  this  stage,  this  strat-
egy  is  not  recommended  in  all  cases  of  failing  Fontan;  it
should  probably  be  limited  to  patients  with  demonstrated
back  ﬂow  in  the  abdominal  venous  system.  Systemic  review
of  detailed  echocardiographical  ﬁndings  in  supine  and  pro-
clive  positions  should  be  obtained  in  this  population  before
considering  such  therapy.
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